Published in Medical Devices and Surgical Technology Week, December 4th, 2005
The net loss in the third quarter of 2005 was $3.1 million, or $0.14 per fully diluted common share, compared to a net loss of $6.0 million, or $0.26 per fully diluted common share in the third quarter of 2004.
Excluding a $412,000, or $0.02 per common share, noncash gain for the change in the value of the derivative related to the company's 6% convertible preferred stock and a $701,000, or $0.03 per common share, charge related to post...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.